ClinicalTrials.gov
public full text
Public Domain
Treatment of Acute Myeloblastic Leukemia in Younger Patients
study of the value of the cytogenetics and the monitoring of the residual minimum disease in the standard treatment of acute myeloblastic leukemia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The burden of leukemia in South Africa: epidemiological trends, economic impact, and priority setting#335358
- Aging of Hematopoietic Stem Cells - Molecular Architecture of Marrow Dysplasia and Clinical Contribution of Ineffective Hematopoiesis to Frailty in the Elderly#837022
- Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies#979376
- National Longitudinal Cohort of Hematological Diseases#806657
- Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia#1089036
Record · ID 845123
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive